Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

22.10
Delayed Data
As of Sep 28
 -0.14 / -0.63%
Today’s Change
11.60
Today|||52-Week Range
24.57
+14.57%
Year-to-Date

Today’s Trading

Previous close22.24
Today’s open22.24
Day’s range21.74 - 22.25
Volume613,171
Average volume (3 months)679,030
Market cap$816.9M
Dividend yield--
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-97.52%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+254.19%
P/E ratio8.7
Price/Sales7.26
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...+0.22+0.89%
MNTAMomenta Pharmaceutic...-0.05-0.42%
ANIPANI Pharmaceuticals ...-0.60-0.88%
BPMCBlueprint Medicines ...+0.79+2.85%
Data as of 09/28/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.38
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs